Publications by Dr David Koss - ePrints

Browsing publications by Dr David Koss.

Newcastle Authors	Title	Year
Dr David Koss Dr Pawel Palmowski Dr Andrew Porter Dr Lauren Walker Professor Johannes Attems et al.	A reciprocal relationship between markers of genomic DNA damage and alpha-synuclein pathology in dementia with Lewy bodies	2025
Dr David Koss Professor Tiago Outeiro	Altered hippocampal doublecortin expression in Parkinson's disease	2024
Professor David Steel Dr David Koss	Surgical classification for large macular hole: based on different surgical techniques results: the CLOSE study group	2023
Dr Paul Donaghy Dr Simon Cockell Dr Carmen Martin-Ruiz Dr Jonathan Coxhead Dr Joseph Kane et al.	Blood mRNA expression in Alzheimer’s disease and dementia with Lewy bodies	2022
Dr David Koss Dr Daniel Erskine Dr Andrew Porter Dr Pawel Palmowski Professor Johannes Attems et al.	Nuclear alpha-synuclein is present in the human brain and is modified in dementia with Lewy bodies.	2022
Chris Hatton Dr David Koss Dr Lauren Walker Professor Tiago Outeiro Professor Johannes Attems et al.	Prion-like α-synuclein pathology in the brain of infants with Krabbe disease	2022
Dr David Koss Professor Tiago Outeiro	Dysfunction of RAB39B-Mediated Vesicular Trafficking in Lewy Body Diseases	2021
Dr Kirsty McAleese Mohi Miah Dr Lauren Walker Mary Johnson Dr Sean Colloby et al.	Frontal white matter lesions in Alzheimer’s disease are associated with both small vessel disease and AD-associated cortical pathology	2021
Dr Daniel Erskine Dr David Koss Professor Viktor Korolchuk Professor Tiago Outeiro Professor Johannes Attems et al.	Lipids, lysosomes and mitochondria: insights into Lewy body formation from rare monogenic disorders	2021
Dr David Koss Odeta Bondarevaite Professor Johannes Attems Professor Tiago Outeiro	RAB39B is redistributed in dementia with Lewy bodies and is sequestered within aβ plaques and Lewy bodies	2021
Dr Kirsty McAleese Dr Lauren Walker Dr Daniel Erskine Mary Johnson Dr David Koss et al.	Concomitant LATE-NC in Alzheimer's disease is not associated with increased tau or amyloid-β pathological burden	2020
Dr David Koss	Synaptic Loss, ER Stress and Neuro-Inflammation Emerge Late in the Lateral Temporal Cortex and Associate with Progressive Tau Pathology in Alzheimer’s Disease	2020
Dr David Koss Professor Tiago Outeiro	Synucleinopathies: Where we are and where we need to go	2020
Dr David Koss Professor Tiago Outeiro	In vitro models of synucleinopathies: informing on molecular mechanisms and protective strategies	2019
Dr David Koss Mary Johnson Professor Johannes Attems Professor Tiago Outeiro	Cytosolic Trapping of a Mitochondrial Heat Shock Protein Is an Early Pathological Event in Synucleinopathies	2019
Professor Tiago Outeiro Dr David Koss Dr Daniel Erskine Dr Lauren Walker Dr Marzena Kurzawa-Akanbi et al.	Dementia with Lewy bodies: an update and outlook	2019
Dr David Koss	Pore-former enabled seeding of tau in rats: Alleviation by memantine and lithium chloride	2019
Dr David Koss	Distinctive temporal profiles of detergent-soluble and -insoluble tau and Aβ species in human Alzheimer's disease	2018
Dr David Koss	Alzheimer's disease pathology and the unfolded protein response: prospective pathways and therapeutic targets	2017
Dr David Koss	Mutant Tau knock-in mice display frontotemporal dementia relevant behaviour and histopathology	2016
Dr David Koss	Neuronal human BACE1 knockin induces systemic diabetes in mice	2016
Dr David Koss	Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer's disease and track disease progression and cognitive decline.	2016
Dr David Koss	Polymeric alkylpyridinium salts permit intracellular delivery of human Tau in rat hippocampal neurons: requirement of Tau phosphorylation for functional deficits.	2015
Dr David Koss	Knock-in of human BACE1 cleaves murine APP and reiterates Alzheimer-like phenotypes	2014
Dr David Koss	18F-barbiturates are PET tracers with diagnostic potential in Alzheimer's disease	2013